Hormone Replacement and Treatment Goals
At a Glance
Vitamin D-dependent rickets requires treatment tailored to the subtype: active or bypassed vitamin D forms plus carefully measured calcium may replace the missing pathway. Frequent blood, urine, and kidney ultrasound checks help balance treatment and detect complications.
Treating Vitamin D-Dependent Rickets (VDDR) is not about “taking vitamins” in the traditional sense. It is a form of hormone replacement therapy. Because your child’s body cannot produce or use the active hormone on its own, doctors must provide the exact missing piece of the biological pathway [1][2].
Standard over-the-counter Vitamin D (cholecalciferol) usually fails for the most common subtypes (like 1A and 2A) because it requires the very “workstations” in the body that are defective to work correctly [1][3].
Subtype-Specific Treatments
Your child’s treatment plan is built specifically for their genetic defect. Never start, stop, substitute products, or alter doses without your specialist’s explicit instructions.
VDDR1A: Bypassing the Kidney
Since the kidneys cannot fully activate the Vitamin D signal, the treatment is to bypass this step.
- Active Hormone Replacement: Doctors usually prescribe calcitriol (which is already fully active) or alfacalcidol (a prodrug that is activated in the liver, bypassing the kidney) [2][4].
- Calcium Support: Because the goal is to harden the bones, children also take precise doses of elemental calcium (the actual amount of calcium in the supplement, not the total pill weight) [5]. Doses are carefully adjusted based on the child’s weight and regular blood tests [5].
VDDR1B: Bypassing the Liver
In this rare form, the liver cannot start the activation process.
- Calcifediol or High-Dose Cholecalciferol: Calcifediol (25-hydroxyvitamin D) directly bypasses the liver defect but still relies on the kidney to finish the activation. In some cases with an intact kidney pathway, specialized high-dose cholecalciferol may also be an effective treatment [6][7].
VDDR2A (HVDRR): Overcoming Resistance
This is the most challenging form to treat because the body resists Vitamin D signals.
- High-Dose Therapy: Treatment often requires very high, specialist-directed doses of oral calcium and active Vitamin D to try to push past the cellular resistance [8][9].
- IV Calcium Infusions: If oral doses cannot safely correct severe, refractory hypocalcemia (dangerously low blood calcium), a hospital admission for intravenous (IV) calcium may be required. In rare, severe cases, a long-term central line (like a PICC or port) may be placed for intermittent infusions. This is a high-risk specialist option that carries significant risks of infection and blood clots [10][11].
- Cinacalcet: In difficult cases where the Parathyroid Hormone (PTH) remains dangerously high despite calcium treatment, doctors may consider adding cinacalcet. This is an off-label adjunct drug with limited evidence that “tricks” the parathyroid glands into slowing down. However, it carries a real risk of worsening hypocalcemia and is not a routine next step [12][13].
Monitoring and Safety
Because the doses used in VDDR are highly specialized, treatment requires a delicate balancing act.
- Blood and Urine Tests: Your child will need frequent labs to check calcium, phosphate, and PTH levels. Doctors also check urine to make sure the kidneys aren’t being overwhelmed with excreted calcium [14][15].
- Kidney Protection: A major risk of high-dose treatment is nephrocalcinosis (calcium deposits in the kidneys). Even if blood tests look perfect, calcium can still build up in the kidneys [14][16]. Regular renal ultrasounds are essential [4][17].
- Consistency is Key: Missing even a few doses can cause calcium levels to drop, leading to emergencies [4][9]. If your child develops symptoms like extreme thirst, frequent urination, nausea, or severe lethargy, contact your specialist immediately, as these can be signs of hypercalcemia (too much calcium) or urinary calcium excess [14].
Common questions in this guide
Why does ordinary vitamin D usually not treat vitamin D-dependent rickets?
What treatment is usually used for VDDR1A?
How is difficult VDDR2A treated when calcium stays dangerously low?
How does the care team monitor treatment and protect the kidneys?
What symptoms should prompt a call to the specialist?
Could cinacalcet help if parathyroid hormone remains high?
Get notified when new evidence is published on Hypocalcemic vitamin D-resistant rickets.
We monitor PubMed for new peer-reviewed studies on this topic and email a short summary when something meaningful changes.
References
References (17)
- 1
Hereditary disorders of vitamin-D metabolism and its receptor.
Lainis V, Katsouli O, Gazi S, et al.
Hormones (Athens, Greece) 2025; (24(2)):335-346 doi:10.1007/s42000-025-00630-w.
PMID: 39893280 - 2
Genetic disorders of Vitamin D biosynthesis and degradation.
Miller WL
The Journal of steroid biochemistry and molecular biology 2017; (165(Pt A)):101-108 doi:10.1016/j.jsbmb.2016.04.001.
PMID: 27060335 - 3
Clinical spectrum and diagnostic challenges of vitamin D dependent rickets type 1A (VDDR1A) caused by CYP27B1 mutation in resource limited countries.
Aftab S, Khan SA, Malik MI, et al.
Journal of pediatric endocrinology & metabolism : JPEM 2023; (36(2)):152-157 doi:10.1515/jpem-2022-0550.
PMID: 36524979 - 4
Genotype-phenotype Description of Vitamin D-dependent Rickets 1A: CYP27B1 p.(Ala129Thr) Variant Induces a Milder Disease.
Méaux MN, Harambat J, Rothenbuhler A, et al.
The Journal of clinical endocrinology and metabolism 2023; (108(4)):812-826 doi:10.1210/clinem/dgac639.
PMID: 36321535 - 5
The genetics and clinical manifestations of patients with vitamin D dependent rickets type 1A.
Ozden A, Doneray H
Journal of pediatric endocrinology & metabolism : JPEM 2021; (34(6)):781-789 doi:10.1515/jpem-2020-0691.
PMID: 33823104 - 6
Vitamin D-Dependent Rickets Type 1B (25-Hydroxylase Deficiency): A Rare Condition or a Misdiagnosed Condition?
Molin A, Wiedemann A, Demers N, et al.
Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research 2017; (32(9)):1893-1899 doi:10.1002/jbmr.3181.
PMID: 28548312 - 7
Calcifediol: a review of its pharmacological characteristics and clinical use in correcting vitamin D deficiency.
Jodar E, Campusano C, de Jongh RT, Holick MF
European journal of nutrition 2023; (62(4)):1579-1597 doi:10.1007/s00394-023-03103-1.
PMID: 36862209 - 8
Hereditary vitamin D-resistant rickets: a report of four cases with two novel variants in the VDR gene and successful use of intermittent intravenous calcium via a peripheral route.
Abalı S, Tamura M, Turan S, et al.
Journal of pediatric endocrinology & metabolism : JPEM 2020; (33(4)):557-562.
PMID: 32049653 - 9
Persistent Hyperparathyroidism in Vitamin D-Dependent Rickets Type 2A Does Not Prevent Normalization of Hypophosphatemia or Healing of the Rickets.
Lodefalk M, Nilsson O
Hormone research in paediatrics 2026; (99(6)):824-833 doi:10.1159/000546444.
PMID: 40383122 - 10
Experience of intravenous calcium treatment and long-term responses to treatment in a patient with hereditary vitamin D-resistant rickets resulting from a novel mutation.
Bayramoğlu E, Şavaş Erdeve Ş, Shi Y, et al.
Journal of pediatric endocrinology & metabolism : JPEM 2019; (32(6)):647-651 doi:10.1515/jpem-2018-0399.
PMID: 31141481 - 11
Successful intermittent intravenous calcium treatment via the peripheral route in a patient with hereditary vitamin D-resistant rickets and alopecia.
Ersoy B, Kiremitci S, Isojima T, Kitanaka S
Hormone research in paediatrics 2015; (83(1)):67-72 doi:10.1159/000367711.
PMID: 25573344 - 12
The Effectiveness of Cinacalcet as an Adjunctive Therapy for Hereditary 1,25 Dihydroxyvitamin D3-Resistant Rickets.
Akıncı A, Dündar İ, Kıvılcım M
Journal of clinical research in pediatric endocrinology 2017; (9(2)):172-178 doi:10.4274/jcrpe.3486.
PMID: 27796266 - 13
Cinacalcet treatment experience in hereditary vitamin D resistant rickets.
Lucas J, Badia JL, Lucas E, Remon A
Journal of pediatric endocrinology & metabolism : JPEM 2020; (33(2)):313-318.
PMID: 31926093 - 14
Clinical and genetic analysis of two Chinese families with vitamin D-dependent rickets type IA and follow-up.
Li Y, Yuan X, Chen R, et al.
Orphanet journal of rare diseases 2020; (15(1)):273 doi:10.1186/s13023-020-01558-7.
PMID: 33004071 - 15
Clinical characteristics and long-term outcomes of 12 children with vitamin D-dependent rickets type 1A: A retrospective study.
Lin Y, Guan Z, Mei H, et al.
Frontiers in pediatrics 2022; (10()):1007219 doi:10.3389/fped.2022.1007219.
PMID: 36405822 - 16
Lifelong deformities in an adult caused by vitamin D‑dependent rickets type 1A: A case report.
Yi C, Xu J, He J, et al.
Experimental and therapeutic medicine 2022; (24(6)):762 doi:10.3892/etm.2022.11698.
PMID: 36561972 - 17
A Case of Vitamin D-Dependent Rickets Type 1A with a Novel Mutation in the Uzbek Population.
Özcabı B, Tahmiscioğlu Bucak F, Jaferova S, et al.
Journal of clinical research in pediatric endocrinology 2016; (8(4)):484-489 doi:10.4274/jcrpe.3128.
PMID: 27353739
This page is for informational purposes only and does not constitute medical advice. A pediatric endocrinologist or other specialist should guide your child’s hormone replacement, calcium dosing, and monitoring.